Leadership

Nancy M. Ruiz, MD, FACP, FIDSA

Nancy M. Ruiz, MD, FACP, FIDSA

Chief Medical Officer

Nancy M. Ruiz, MD, joined Larimar Therapeutics in March 2020 as Chief Medical Officer bringing over 24 years of global experience in all phases of clinical development and medical affairs. She has broad cross-therapeutic experience including infectious diseases, rheumatoid arthritis, transplant, immunology, asthma, allergy, women’s and men’s health and neonatal hyperbilirubinemia.

Prior to joining Larimar, Dr. Ruiz was Vice President of Clinical Development and Head of Drug Safety at Prolong Pharmaceuticals. She previously served as Chief Medical Officer for InfaCare Pharmaceutical where she led clinical and regulatory strategy. Dr. Ruiz was also Chief Medical Officer of Meda Pharmaceuticals where she led clinical operations, medical affairs, regulatory affairs, scientific affairs, pharmacovigilance, health economics & outcomes research and quality assurance. She has also held leadership roles at Schering-Plough Research Institute, Merck Research Laboratories, Optimer Pharmaceuticals, Bristol-Myers Squibb and DuPont Pharmaceuticals.

Dr. Ruiz received her BA from Temple University and her MD from Ponce School of Medicine. She completed her residency in Internal Medicine and a fellowship in Infectious Diseases. Dr. Ruiz is a Fellow of the American College of Physicians and the Infectious Disease Society of America.

Back to Leadership >